Impairment of the neuronal dopamine transporter activity in MPP+-treated rat was not prevented by treatments with nitric oxide synthase or poly(ADP-ribose) polymerase inhibitors
- 30 October 2001
- journal article
- research article
- Published by Elsevier in Neuroscience Letters
- Vol. 314 (1-2) , 82-86
- https://doi.org/10.1016/s0304-3940(01)02273-x
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- A new in vitro approach for investigating the MPTP effect on DA uptakeNeurochemistry International, 2000
- Poly(ADP-ribosyl)ation reactions in the regulation of nuclear functionsBiochemical Journal, 1999
- Decreases in mouse brain NAD+ and ATP induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP): prevention by the poly(ADP-ribose) polymerase inhibitor, benzamideBrain Research, 1998
- Animal models of Parkinson's disease: An empirical comparison with the phenomenology of the disease in manJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1996
- 2‐Deoxyglucose Enhances 1‐Methyl‐4‐Phenyl‐1, 2, 3, 6‐Tetrahydropyridine‐Induced ATP Loss in the Mouse BrainJournal of Neurochemistry, 1993
- Kinetics of superoxide dismutase- and iron-catalyzed nitration of phenolics by peroxynitriteArchives of Biochemistry and Biophysics, 1992
- MPTP mechanisms of neurotoxicity and their implications for Parkinson's diseaseEuropean Journal of Pharmacology: Molecular Pharmacology, 1991
- Rapid ATP Loss Caused by 1‐Methyl‐4‐Phenyl‐1,2,3,6‐Tetrahydropyridine in Mouse BrainJournal of Neurochemistry, 1991
- Correlation between (3H) dopamine specific uptake and (3H) GBR 12783 specific binding during the maturation of rat striatumLife Sciences, 1989
- Cellular euthanasia mediated by a nuclear enzyme: a central role for nuclear ADP-ribosylation in cellular metabolismTrends in Biochemical Sciences, 1987